GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Icecure Medical Ltd (NAS:ICCM) » Definitions » COGS-to-Revenue

Icecure Medical (Icecure Medical) COGS-to-Revenue : 0.55 (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Icecure Medical COGS-to-Revenue?

Icecure Medical's Cost of Goods Sold for the three months ended in Dec. 2023 was $0.69 Mil. Its Revenue for the three months ended in Dec. 2023 was $1.26 Mil.

Icecure Medical's COGS to Revenue for the three months ended in Dec. 2023 was 0.55.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Icecure Medical's Gross Margin % for the three months ended in Dec. 2023 was 45.34%.


Icecure Medical COGS-to-Revenue Historical Data

The historical data trend for Icecure Medical's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Icecure Medical COGS-to-Revenue Chart

Icecure Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.65 0.37 0.47 0.53 0.60

Icecure Medical Quarterly Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.51 0.55 0.54 1.07 0.55

Icecure Medical COGS-to-Revenue Calculation

Icecure Medical's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=1.929 / 3.229
=0.60

Icecure Medical's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.686 / 1.255
=0.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Icecure Medical  (NAS:ICCM) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Icecure Medical's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0.686 / 1.255
=45.34 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Icecure Medical COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Icecure Medical's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Icecure Medical (Icecure Medical) Business Description

Traded in Other Exchanges
N/A
Address
7 Haeshel Street, Southern Industrial Park, PO Box 3163, Caesarea, ISR, 3079504
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Icecure Medical (Icecure Medical) Headlines